Close Menu


More Variants to Come

Additional, more contagious variants of SARS-CoV-2 are likely to crop up, the Financial Times says.

The African health technology company 54gene is eager for partnerships with researchers and biopharmaceutical companies alike.

South African researchers are investigating whether COVID-19 vaccines are effective against a SARS-CoV-2 strain recently identified there, the Associated Press reports.

The Globe and Mail reports UK researchers say their discovery of a new strain of SARS-CoV-2 highlights the importance of viral genomic surveillance.

A shipwreck has given researchers a glimpse into the elephants living in West Africa hundreds of years ago, Gizmodo reports.

In PLOS this week: investigation of pleiotropic effects using GWAS data, transcriptomic study of mosquitoes that spread Rift Valley fever, and more.

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Researchers are hoping to make the technology a success for the environment and human health while avoiding the biases that resulted from the debate over GMOs.

In Science this week: single-cell atlases of human fetal gene expression, chromatin accessibility; SARS-CoV-2 antibody prevalence in Kenya; more.


Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.